DrugDashboards

Nicotine Transdermal System Patch Step 3

Nicotine Transdermal System Patch · NICOTINE 7 mg/24h · Patch, Extended Release · Transdermal · BluePoint Laboratories

NDC 68001-0697-88 · 7 PATCH in 1 CARTON / 24 h in 1 PATCH · NDA · View full market →

The short version

Just 2 companies supply this market — thin enough that a single exit would be felt immediately. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$1.00$2.00Jul 2026Sep 2026$1.73
3 price points · per EASource: CMS NADAC

Estimated fill cost

Estimated WAC per unitestimate
$1.787
No Texas or California filing exists for this NDC — this figure is derived, not filed.

This is an ESTIMATE derived from NADAC, not a filed or published price: pharmacies typically acquire brand drugs at roughly 2–4% below list, so list ≈ NADAC ÷ 0.97. Shown only because no state transparency filing exists for this NDC.

Supply fragility

20Low risk

Some pressure is visible, but not much — here’s everything the score found to count.

  • 2 active manufacturers+20

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.2%chance of a new FDA shortage posting for nicotine transdermal system (other) in the next 90 days

price up 18% YoY · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
NDA020076
TE code
Approval date
Nov 12, 1999
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Nicotine Transdermal System Patch (Patch, Extended Release)

LabelerStrengthFirst seenLast seen
BluePoint LaboratoriesNICOTINE 14 mg/24hJul 15, 2026Sep 2, 2026
BluePoint LaboratoriesNICOTINE 21 mg/24hJul 15, 2026Sep 2, 2026
BluePoint LaboratoriesNICOTINE 7 mg/24hJul 15, 2026Sep 2, 2026
Dr. Reddy's Laboratories Inc.NICOTINE 14 mg/24hJul 15, 2026Sep 2, 2026
Dr. Reddy's Laboratories Inc.NICOTINE 21 mg/24hJul 15, 2026Sep 2, 2026
Dr. Reddy's Laboratories Inc.NICOTINE 7 mg/24hJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Nicotine Transdermal System Patch Step 3 — NDC 68001-0697-88," retrieved September 3, 2026, https://drugdashboards.com/drug/68001069788.

Free to cite with attribution — see how the data is put together.